Financials
- Market Capitalization 39.12 M
- Employee 12
- Founded 2001
- CEO Joel Latham
- Website www.incannex.com.au
- Headquarter Delaware, United States
- FIGI BBG01J0814Y2
- Industry 药品制造—专业与仿制药
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-0.16
市销率
86.42
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 4273 | INCR Intercure Ltd. - ordinary shares | 0.98 USD | +3.16% | +1.03% | +8.89% | -36.77% | 53.59 M USD | ||
| 4346 | SCYX SCYNEXIS, Inc. - Common Stock | 4.62 USD | +3.13% | +1.32% | +8.71% | +470.37% | 45.88 M USD | ||
| 4435 | ZYBT Zhengye Biotechnology Holding Limited - Class A Ordinary Shares | 0.71 USD | 0.00% | +1.43% | -5.33% | -70.90% | 33.65 M USD | ||
| 4553 | CPHI China Pharma Holdings, Inc. Common Stock | 0.58 USD | -3.33% | -17.14% | -26.58% | -12.27% | 23.50 M USD |